Objective: Recent studies con®rmed the deleterious role of glutamate in the pathophysiology of spinal cord ischemia induced by aortic cross-clamping. We investigated the effect of riluzole, an anti-glutamate drug, in a rat model of spinal cord ischemia. Materials and methods: Spinal cord ischemia was induced in normothermia for 14 min in Sprague±Dawley rats using direct aortic arch plus left subclavian artery cross-clamping through a limited thoracotomy. Experimental groups were as follows: sham-operation (n 15), control (n 15) receiving only vehicle, riluzole (n 15) receiving riluzole (4 mg/kg) before clamping and at the onset of reperfusion. Separate animals were used for monitoring physiologic parameters in the sham-operation (n 3), control (n 5), and riluzole (n 5) groups. Neurologic status was assessed at 6, 24 h, and then daily up to 96 h. Rats were randomly killed at 24, 48, or 96 h (n 5 for each time). Spinal cords were harvested for histopathology, immunohistochemistry for microtubule-associated protein 2 (MAP-2), TUNEL staining, and analysis of DNA fragmentation by agarose gel electrophoresis. Results: All sham-operated rats had a normal neurologic outcome, whereas all control rats suffered severe and de®nitive paraplegia. Riluzole-treated rats had signi®cantly better neurologic function compared to the control. Histopathology disclosed severe neuronal necrosis in the lumbar gray matter of control rats, whereas riluzole-treated rats suffered usually mild to moderate injury. Riluzole particularly prevented motor neurons injury. MAP-2 immunoreactivity was completely lost in control rats, whereas it was preserved either completely or partly in riluzole-treated rats. TUNEL staining revealed numerous apoptotic neurons scattered within the whole gray matter of control rats. Riluzole prevented or dramatically attenuated apoptotic neuronal death in treated rats. DNA extracted from lumbar spinal cords of sham-operated and riluzole-treated rats exhibited no laddering, whereas spinal cords from control rats showed DNA laddering with fragmentation into < 180 multiples of base pairs. Conclusions: Riluzole may protect the spinal cord in a setting of severe ischemia by preventing neuronal necrosis and apoptosis. This drug may therefore be considered for clinical use during`high risk' surgical procedures on the thoracoabdominal aorta. q
Introduction
Spinal cord ischemia with resulting paraplegia remains a devastating complication after repair of thoracoabdominal aortic aneurysms or dissection [1, 2] . Recent studies demonstrated the deleterious role played by excitotoxic mechanisms in the pathophysiology of spinal cord ischemia [3, 4] . Riluzole is an anti-excitotoxic drug that has demonstrated ef®cacy in several models of cerebral ischemia and spinal cord injury [5] . Moreover, this drug is in clinical use among patients with amyotrophic lateral sclerosis, since 1995 [5, 6] .
The goal of this study was to observe whether riluzole could consistently prevent spinal cord ischemic injury in a rat model of transient spinal cord ischemia induced by aortic cross-clamping and to analyze whether this drug could prevent neuronal necrosis or apoptosis or both.
Materials and methods

Materials
Sixty-eight Sprague±Dawley male rats weighing 350± European Journal of Cardio-thoracic Surgery 18 (2000) 174±181 400 g were used in this study. All animals were allowed free access to laboratory chow and tap water in day/night regulated quarters at 258C. Animal care and experiments complied with the European Convention on Animal Care and was approved by the local Sub-Committee for Research and Animal Care.
Surgical procedure
Anesthesia was induced in a chamber containing 3% halothane and was maintained by inhalation through a facial mask of 1.5% halothane driven by oxygen 2 l/min. Rectal temperature was continuously monitored with a¯exible probe inserted 7 cm into the rectum, and supported by a thermal pad and a heating lamp. Body temperature was maintained at 37:5^0:58C during the surgical procedure ( Table 1 ). The rats were placed in the supine position and a longitudinal incision was made through the skin in the sternal region. The left jugular vein was used for intravenous injection of drugs or solutions. The chest wall was incised from the apex of the manubrium caudad along the left sternal border, to the third rib. Care was taken to avoid the left superior vena cava and the left internal mammary artery. The thymus was retracted superiorly and the aortic arch was isolated between the left common carotid and the left subclavian arteries, avoiding the left recurrent laryngeal nerve. Heparin (100 UI/kg) was administered intravenously 10 min before aortic clamping. Spinal cord ischemia was induced by aortic arch plus left subclavian artery crossclamping for 14 min, using two Micro Vessel Clips (Catalog No 14-1020, Biomedical Research Instruments, Rockville, MD). Then the clips were removed and the chest was closed in layers. Five milliliters of 0.9% saline were injected intraperitoneally after completion of the surgical procedure. Sham-operated animals underwent an identical surgical procedure except for aortic arch and left subclavian artery clamping. Animals were allowed to recover in a plastic box at 288C for 3 h, and were placed in their cages. The crede Â's manoeuver was used twice daily to empty the urinary bladder of paraplegic animals.
Study groups
Animals were separated in different study groups as follows:
² sham-operation (n 15): operation was performed using similar conditions except for aortic and subclavian artery clamping; ² control (n 15): animals received only vehicle; ² riluzole (n 15): riluzole (4 mg/kg) was injected 30 min before aortic clamping and at the onset of reperfusion.
All rats received a similar volume of solutions: 1 ml for all the procedure. Riluzole (Research Biochemicals International, Natick, MA) was ®rst dissolved in 0.1 N hydrochloric acid then diluted in distilled water.
Measurement of mean arterial blood pressure (MABP)
Separate groups of animals were anesthetized using similar conditions: sham-operation (n 3), control (n 5), riluzole (n 5). An intravenous catheter (24 G) was inserted in the tail artery and connected via a transducer to a pressure monitor (Hewlett-Packard, Palo Alto, CA) for continuous monitoring of distal MABP. Distal arterial blood pressure was monitored throughout the procedure. Catheter was removed after 30 min of reperfusion, and the tail incision was closed.
Evaluation of neurobehavioral outcome
Serial assessments of motor and sensory functions in the hindlimbs of all rats were performed at 6, 24 h, and then daily up to 96 h of reperfusion, using the score of Le May et al. [7] with modi®cations:
(a) walking with lower extremities:
² 0, normal; ² 1, toes¯at under body when walking but ataxia is present; ² 2, knuckle walking; ² 3, movements in lower extremities but unable to knuckle walk; ² 4, no movement, drags lower extremities. ² 0, normal, withdrawal to toe pinch; ² 1, squeals to toe pinch but does not withdraw; ² 2, no reaction to toe pinch.
A motor sensory de®cit index (MSDI) was calculated for each animal at each time point. The ®nal index was the sum of the scores (a) and (b), and the maximum de®cit was indicated by a score of 6. a MABP, distal mean arterial blood pressure, measured in the tail artery; preischemia, value measured within 1 min before clamping; 5 min ischemia, value measured after 5 min of aortic clamping; 30 min reperfusion, value measured 30 min after unclamping. Physiologic data were analyzed with one way ANOVA analysis of variance. Statistically signi®cant difference among experimental groups is expressed by *.
Euthanasia
Animals were randomly assigned to sacri®ce at 24, 48, or 96 h of reperfusion (n 5 for each time, in each group). Animals were anesthetized with 3% halothane and transcardially perfused with 100 ml of 0.9% saline solution at 48C. Spinal cords were quickly harvested, and placed either in fresh 4% paraformaldehyde at 48C for 48 h, or frozen in isopentane on dry ice and stored at 2808C until use.
Histopathology
Spinal cords were removed from 4% paraformaldehyde after 48 h ®xation. Specimens were dehydrated in alcohol 95% for 30 min, followed by four changes of 100% alcohol for 1 h each and ®ve changes of toluene for 1 h each under vacuum at 378C. Spinal cords were in®ltrated with paraf®n and embedded in paraf®n at 578C under vacuum and pressure. Transverse sections were made on a microtome (Leica). Ten micrometer-sections were obtained through the lumbar spinal cord. Sections were stained with hematoxylin and eosin (H&E) and the luxol fast blue staining method and were examined under the light microscope. All animals had their spinal cord examined. The neuropathologist who performed examination was blinded to the experimental conditions. The Rexed's classi®cation was used to describe the locations of damaged neurons in gray matter [8] .
Immunohistochemistry for MAP-2
Sections were immersed in 0.3% H 2 O 2 for 10 min, blocked with 5% goat serum (Vector Labs) and 3% Triton for 1 h at room temperature, followed by a rinse in PBS. Then sections were incubated with the primary antibody overnight. The antiserum used for the study of cytoskeletal protein expression was a monoclonal mouse anti-MAP-2 (Clone HM-2, Sigma, diluted 1:500). After the primary incubation and three rinses in PBS, sections were incubated in biotinylated horse anti-mouse IgG (diluted 1:100, Vector Labs.) for 3 h. MAP-2 expression was visualized by 3 Hdiaminobenzidine and nickel chloride (DAB-Ni) staining using the Vectastain ABC kit (Vector Labs.). All sections were washed a ®nal time in PBS and distilled water, and then mounted with glycerol. Sections were examined under the light microscope.
Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick-end labeling (TUNEL) staining method
Coronal 10 mm sections were used and processed according to the TUNEL method as described by Gavrieli et al. [9] . The in situ cell death detection kit (Hoffmann±La Roche Ltd., Basel, Switzerland) and VectaStain ABC kit (Vector Laboratories, Inc., Burlingame, CA) were used for this purpose. Cells with nuclei frankly stained by the TUNEL method or containing apoptotic bodies were considered to be apoptotic. Neurons which nuclei exhibited very faint TUNEL staining and that did not contain apoptotic bodies were considered to be necrotic.
Analysis of DNA fragmentation by agarose gel electrophoresis
Six separate animals were operated: sham-operation (n 2), control (n 2), and riluzole (n 2) and sacri®ced at 24 h of reperfusion using the technique described previously. Rats were perfused with 100 ml of 48C cold saline and the lumbar spinal cord harvested quickly and ash frozen in liquid nitrogen before storing at 2808C. the Puregene DNA isolation kit (Gentra Systems, Minneapolis, MN) was used to extract DNA from lumbar spinal cords. DNA electrophoresis was performed as described by Du et al. [10] .
Statistical analysis
Statistical analyses of measured physiologic data were performed by one-way ANOVA analysis of variance. All physiologic data are expressed as mean^SE. Neurologic scores were analyzed with Kruskal±Wallis tests followed by Mann±Whitney U-tests when signi®cant. Differences were considered statistically signi®cant for P , 0:05.
Results
Neurobehavioral outcome
Three rats in the control group (20%) and one (6.6%) in the riluzole group died either during or after operation (left superior vena cava wound 1, right pneumothorax 1, postoperative bowel ischemia 2). Those rats were replaced by other rats to reach the appropriate n in each group. All rats survived the entire randomly assigned observation period. All sham-operated rats had a normal postoperative neurologic outcome, whereas all control rats had a MSDI of 6 at 6 h and 24 h, and remained severely paraplegic throughout the observation period with no improvement in either sensory or motor function. Control rats had¯accid paraplegia after recovery from anesthesia and either developed spasticity within 6 h or exhibited¯accid paraplegia until sacri®ce. They also suffered urinary bladder dilatation. Five of 17 rats (29%) suffered temporary pain-like response to light touch known as allodynia during the ®rst 24 h of reperfusion. Neurologic outcome was signi®cantly better in riluzole-treated rats at any time considered (Table 2 ). All riluzole-treated rats had delayed recovery from anesthesia (1±3 h) consistent with anesthetic properties of riluzole [5] . All riluzole-treated rats had some form of¯accid paraplegia after recovery from anesthesia, but began to recover motor function between 3 and 6 h postoperatively. At 24 h, 66.6% of rats had a completely normal motor function, whereas 33.3% suffered mild to middle de®cit. Partial or complete sensory de®cit was diagnosed in 60% of rats. These results persisted at 48 h, and at 96 h 60% of rats had a normal motor and sensory function, whereas 40% suffered middle motor de®cit and severe sensory de®cit.
Histopathology
H&E and luxol fast blue staining were used to analyze neuronal cell death in gray matter. The extent of ischemic damage was grossly proportional to the neurologic score. Ischemic damage was observed almost exclusively in gray matter, which contained typically necrotic neurons with eosinophilic cytoplasm (`red neurons') and loss of cytoplasmic structures (`ghost neurons'), but also neurons demonstrating apoptotic features as shrinkage, chromatin condensation, and apoptotic bodies. Sham-operated rats had normal spinal cords. All control rats had very severe ischemic injury with global necrosis of gray matter. In most severe cases, white matter surrounding gray matter was also damaged in spinal cord sections of rats sacri®ced at 48 h, or later. Most riluzole-treated rats (MSDI 0±2) had either no or mild neuronal damage predominantly in laminae 3 to 7 and 10 in gray matter. Riluzole-treated rats with MSDI 3±4 had variable-size con¯uent necrotic areas predominantly in laminae 3 to 7 and 10. Laminae 1 and 2 in dorsal horns. Lamina 8 and lamina 9 containing motor neurons were variably affected depending on the neurologic status. Motor neurons were usually not injured with MSDI of 3, whereas less than 50% were injured with MSDI being 4 ( Fig. 1 ).
Immunohistochemistry for MAP-2
The cytoskeletal protein MAP-2 is involved in maintaining neuronal structural integrity. It is extremely sensible to ischemic insult and immunoreactivity for MAP-2 has been demonstrated to be a sensitive, accurate and early marker of central nervous system injury following ischemia [11] . The spatial distribution for loss of MAP-2 immunoreactivity paralleled ischemic injury de®ned by H&E staining. MAP-2 immunoreactivity was strongly expressed throughout gray matter of sham-operated rats, particularly in neuronal perikaryon and dendrites. Spinal cord from control rats exhibited a complete loss of MAP-2 immunoreactivity throughout gray matter (laminae 1 to 10) as early as 24 h following ischemia. Spinal cord from riluzole-treated rats exhibited either grossly normal MAP-2 immunoreactivity (MSDI 0±2), or focal decrease of MAP-2 immunoreactivity in dorsal horns body (laminae 3 to 6) and intermediate zone (lamina 7) (MSDI 3±4) (Fig. 2) .
TUNEL staining
Spinal cords from sham-operated rats showed no evidence of TUNEL staining. When treated with DNAase, those cords demonstrated TUNEL-stained nuclei (data not shown). Spinal cord samples from control rats showed numerous TUNEL-positive neurons scattered within gray matter. Numbers of TUNEL-positive neurons increased in the ventral to dorsal direction. They were most highly concentrated in laminae 1 and 2, then in laminae 3 to 7 and 10. Laminae 8 and 9 contained usually less TUNELpositive cells. The number of TUNEL-positive cells increased from 24 h, reached a peak at 48 h and decreased after that. Spinal cords from riluzole-treated rats showed very few to numerous TUNEL-positive neurons scattered within intermediate gray matter and dorsal horns body, depending on the neurologic status of the rat (Fig. 3 ). There were usually no TUNEL-positive neurons in ventral horns. The total number of apoptotic neurons within gray matter was less in all riluzole-treated rats compared to control rats (Fig. 3) .
DNA fragmentation study
DNA extracted from the whole lumbar spinal cord from sham-operated rats exhibited no laddering, whereas DNA from control rats showed a ladder of multiples of <180-bpsized fragments after electrophoresis in agarose gel. DNA extracted from riluzole-treated animals exhibited no laddering (Fig. 4) .
Discussion
Paraplegia resulting from spinal cord ischemia remains a dreaded complication of thoracoabdominal aortic surgery despite various surgical adjuncts and pharmacological interventions [1, 2, 12] . The rat model used in this study has been adapted from Le May et al. [7] . It is highly reproducible, because 100% of control rats operated in strict normothermia and clamped for 14 min suffered severe and de®nitive paraplegia. Operative mortality was low (3%) and severe bowel ischemia occurred in only 10.5% of control rats. Spinal cord arterial vascularization is almost similar in rat and man, with an heterosegmental aorta and few anterior radicular arteries reaching the anterior spinal artery [13] . Combined clamping of both aortic arch and left subclavian artery reproduces the operative situation encountered during repair of the descending thoracic or thoracoabdominal aorta. Blood¯ow not only to the spinal cord, but also to liver, bowel and kidneys is dramatically reduced during the clamping period [12, 13] . Thus, no speci®c problem such as metabolic acidosis, bacterial translocation, coagulopathy, or renal failure, is occulted in this model. This is of importance because in the rabbit model of spinal cord ischemia, that has been the most widely used for the past 15 years, the aorta is cross-clamped below the renal arteries, occulting by this fact additional problems that may interfere with the level of neuronal damage in the spinal cord [14] .
Recent studies demonstrated the deleterious role played by excitotoxic mechanisms in the pathophysiology of spinal cord ischemic injury due to aortic cross-clamping [3, 4] . Drugs aimed at blocking excitotoxicity as NMDA and non-NMDA receptor antagonists have demonstrated ef®-cacy in several animal models of cerebral or spinal cord ischemia [3,15±17] . However, none of these drug consistently proved ef®cacy in clinical trials and the potential for Fig. 4 . DNA fragmentation measured by agarose gel electrophoresis. Gel electrophoresis of DNA extracted from animals that underwent shamoperation (S), 14-min ischemia (C), 14-min ischemia 1 riluzole treatment (R), and DNA extracted from a normal rat that was sacri®ced without any operation (N). DNA extracted from sham-operated rats (S), normal rat (N), and riluzole-treated rats (R) exhibit no laddering, whereas DNA extracted from control (C) rats exhibit laddering consistent with the presence of DNA fragments with lengths being multiples of 180 base pairs (bp). DNA marker positions in base pairs are shown on the left. (1) or (2) indicates the presence or absence of laddering. serious adverse effects and morphological neuronal changes associated with this class of compounds limit their clinical use [17, 18] . Riluzole is a neuroprotective drug that has demonstrated anti-ischemic properties in several models of cerebral ischemia [5] . The exact molecular target of riluzole is unknown yet, but its mechanism of action include an inhibition of presynaptic release of glutamate, an inactivation of both sodium and calcium ion voltage-dependent channels, a direct but noncompetitive inhibition of NMDA receptors, and an activation of a recently discovered class of background potassium ion channels that are highly expressed in brain and spinal cord [5, 19, 20] . In addition, recent studies indicated that riluzole could improve mitochondrial function and increase sodium ion-dependent glutamate reuptake after spinal cord injury [21] . In vitro, riluzole has been reported particularly ef®cient for motoneuronal protection [5] . Moreover, as a sodium ion channel blocker, riluzole may also be effective on white matter injuries that have been reported after incomplete spinal cord ischemia [17, 22, 23] .
Although neuronal death carried by excitotoxic mechanisms has been classically attributed to necrosis, recent reports demonstrated that apoptosis, a form of programmed cell death, may also be triggered by excessive excitatory amino-acids release, free radicals formation occurring after spinal cord ischemia/reperfusion, or activation and cleavage of caspases [24±26] . The present study demonstrates that riluzole injected intravenously before aortic clamping and at unclamping may prevent both necrosis and apoptosis of spinal cord neurons. Histopathologic examination of spinal cords harvested on most riluzole-treated animals showed either no or very little evidence of necrotic injury, whereas spinal cords from control rats exhibited extensive necrotic injury throughout gray matter. Those ®ndings were con®rmed by MAP-2 immunohistochemistry: riluzole-treated rats had preserved immunoreactivity, whereas control rats had evidence of extensive cytoskeletal protein MAP-2 breakdown, that is known to be an early and sensitive marker of acute ischemic injury. Compared with control rats, there were fewer TUNEL-positive neuronal cells in the gray matter of most riluzole-treated rats, and no laddering could be found in DNA samples obtained from those rats, suggesting that neuronal apoptosis was also ef®ciently prevented or attenuated by riluzole (Table 3) .
Neither perioperative hypothermia nor increase in arterial blood pressure can account for the protective effect of riluzole observed in this study, because rectal temperature and arterial blood pressure were closely monitored and did not differ among experimental groups (Table 1) . Riluzole is currently in clinical use among patients with amyotrophic lateral sclerosis since 1995 [5, 6] . Except for one case of temporary liver dysfunction, no major side effects have been reported with chronic treatment 100±200 mg/day over a 4-year period [27] . Although higher dose may be required for adequate neuroprotection (4±8 mg/kg), it seems highly improbable that a single 8 mg/kg injection may result in major adverse effects in closely monitored patients undergoing major aortic surgery. We anticipate that riluzole may have important implications in clinical situations as thoracoabdominal aortic surgery or aortic arch surgery, that can trigger excitotoxicity in the spinal cord or brain, respectively [4, 28] . In these particular situations a single injection of riluzole before aortic clamping or circulatory arrest may prevent neuronal necrosis and apoptosis by extending ischemic tolerance before adequate brain or spinal cord perfusion could be reestablished. Riluzole may also be of special interest during repair of traumatic isthmic aortic rupture, by extending ischemic tolerance of the spinal cord and making distal perfusion methods and high dose heparin unnecessary.
Conclusions
Riluzole provided robust protection against neuronal necrosis and apoptosis in a highly reproducible rat model of spinal cord ischemia. We anticipate that riluzole may have important clinical implications during`high risk' surgical procedures on the descending thoracic or thoracoabdominal aorta.
